2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-基]乙酰氯 | 20357-37-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-基]乙酰氯
• 英文名称: 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl chloride
• 英文别名: 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetyl chloride；1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl chloride；indomethacin chloride；2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl chloride
• CAS: 20357-37-3
• 化学式: C₁₉H₁₅Cl₂NO₃
• 分子量: 376.239
• InChiKey: VCVWWGAKIXAYTN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  48.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-基]乙酰氯 在 4-二甲氨基吡啶 、 N,N'-二环己基碳二亚胺 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 为溶剂， 生成 2-methoxy-4-methylphenyl (S)-1-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl) acetyl)pyrrolidine-2-carboxylate
  参考文献：
  名称：

  Compounds against inflammation and oxidative insult as potential agents for neurodegenerative disorders

  摘要：

  Amides of proline, a feature encountered in nootropics, via the carboxylic group of ibuprofen, indomethacin, ketoprofen and naproxen were prepared. Proline carboxylic group was amidated or esterified with potential antioxidant or neuroprotective compounds. Proline was replaced by 4-hydroxyproline, 2-pipecolic acid or omitted, for investigating the contribution of structure to activity. Anti-inflammatory activity was determined, and selected compounds were examined for anti-dyslipidemic action, protection against brain ischaemia/reperfusion and brain penetration.Amides of proline and related structures with NSAIDs were synthesized. They were amidated or esterified with antioxidant or neuroprotective compounds. Activity against lipid peroxidation, inflammation and brain ischaemia was evaluated.

  DOI：

  10.1007/s00044-011-9726-x
• 作为产物：
  描述：

  吲哚美辛 在 草酰氯 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 生成 2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-基]乙酰氯
  参考文献：
  名称：

  酰氯与单质硫和氟碘甲烷直接合成单氟甲基硫酯

  摘要：

  已经开发出一种实用的镍催化酰氯合成单氟甲基硫酯的方法。在该方案中，首先形成酰氯中间体，然后与 S 8 和 ICH 2 F 进行镍催化的交叉偶联反应，以中等到高的速度生成相应的产物。产量。

  DOI：

  10.1002/ejoc.202400296

文献信息

• Design synthesis and cytotoxicity studies of some novel indomethacin-based heterocycles as anticancer and apoptosis inducing agents
  作者：Marwa F. Harras、Rehab Sabour、Yousry A. Ammar、Ahmed B.M. Mehany、Amel M. Farrag、Sally I. Eissa

  DOI：10.1016/j.molstruc.2020.129455

  日期：2021.3

  values ranging 0.83–1.54 µM. A mechanistic study of the most active compound against the HCT-116, HT-29 and Caco-2 cell lines revealed cell cycle arrest during the G2/M phase. Compound 12 was found to induce apoptosis through the up-regulation of Bax and p53 by 7.4 and 8.5-fold, respectively, and also the downregulation of Bcl-2 by 3.2-fold compared to the control. Western blot assay was performed on HCT-116

  摘要 吲哚美辛是一种众所周知的非甾体抗炎药，具有细胞毒活性。在这项研究中，使用简单的化学方法合成了一系列结构相关的新吲哚美辛类似物，及其对五种不同人类癌细胞系（结肠癌细胞系 HCT-116、HT-29 和 Caco-2，肝细胞系）的细胞毒性作用HepG-2 和乳腺细胞系 MCF-7) 进行了评估。大多数测试的化合物显示出有效的抗癌活性，尤其是对三种结肠癌细胞系。在所有测试的衍生物中，与母体药物吲哚美辛和参考化合物 5-氟尿嘧啶相比，化合物 12 显示出最有效的细胞毒活性，IC50 值范围为 0.83–1.54 µM。对 HCT-116 活性最强的化合物的机理研究，HT-29 和 Caco-2 细胞系在 G2/M 期显示细胞周期停滞。与对照相比，发现化合物 12 通过将 Bax 和 p53 分别上调 7.4 倍和 8.5 倍以及下调 Bcl-2 3.2 倍来诱导细胞凋亡。对 HCT-116 细胞进行了蛋白质印迹分析，结果表明
• Esters and amides containing the
  申请人：Dr. Karl Thomae GmbH

  公开号：US04362738A1

  公开（公告）日：1982-12-07

  Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino; R.sub.1 is hydrogen, fluorine, chlorine or bromine; R.sub.2 and R.sub.3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms; R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino; A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one ##STR2## where R.sub.1, R.sub.2 and R.sub.3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety; B is the acyl residue of an antiphlogistic carboxylic acid; and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.

  公式##STR1##的化合物，其中每个X可以相同也可以不同于其他X，是氧或亚胺；R.sub.1是氢，氟，氯或溴；R.sub.2和R.sub.3，可以相同也可以相互不同，都是氢；未取代或单取代的1到6碳原子的烷基，其中取代基是苯基或1到3碳原子的二烷基氨基；吡啶基；或5到7碳原子的环烷基；R.sub.2和R.sub.3，与彼此以及它们所连接的氮原子一起，是吡咯烷基，哌啶基，己亚胺基，吗啉基，N-芳基哌嗪基或N-(1到3碳原子的烷基)哌嗪基；A是5到7碳原子的环烷基；未取代或取代的2到10碳原子的亚烷基，其中取代基是一到两个每个含有1到3碳原子的烷基，一到两个每个含有2到4碳原子的碳烷氧基，一到两个苯基，一到四个羟基，一个卤甲基，一个羟甲基，一个1到18碳原子的烷酰氧基，一个在烷酰基部分含有1到18碳原子的烷酰氧甲基或一个##STR2##其中R.sub.1，R.sub.2和R.sub.3具有先前定义的含义；或2到10碳原子的亚烷基，通过氧，硫，亚砜，磺酰基，苯基，环己基，吡啶基，哌嗪基或未取代或取代的亚胺基中断，其中亚胺基上的取代基是1到6碳原子的烷基，苯基或1到3碳原子的苯烷基；B是一种抗炎的羧酸的酰基残基；以及它们的非毒性，药理学上可接受的酸加成盐。这些化合物以及它们的盐可以用作抗炎药。
• NO-NSAIDs. Part 3: Nitric Oxide-Releasing Prodrugs of Non-steroidal Anti-inflammatory Drugs
  作者：Namdev Borhade、Asif Rahimkhan Pathan、Somnath Halder、Manoj Karwa、Mini Dhiman、Venu Pamidiboina、Machhindra Gund、Jagannath Janardhan Deshattiwar、Sunil Vasantrao Mali、Nitin Janardanrao Deshmukh、Subrayan Palanisamy Senthilkumar、Parikshit Gaikwad、Santhosh Goud Tipparam、Jayesh Mudgal、Milan Chandra Dutta、Aslam Usmangani Burhan、Gajanan Thakre、Ankur Sharma、Shubhada Deshpande、Dattatraya Chandrakant Desai、Nauzer Pervez Dubash、Arun Kumar Jain、Somesh Sharma、Kumar Venkata Subrahmanya Nemmani、Apparao Satyam

  DOI：10.1248/cpb.60.465

  日期：——

  "Safe NSAIDs," we report herein the design, synthesis and evaluation of 21 new NO-NSAIDs of commonly used NSAIDs such as aspirin, diclofenac, naproxen, flurbiprofen, ketoprofen, sulindac, ibuprofen and indomethacin. These prodrugs have NO-releasing disulfide linker attached to a parent NSAID via linkages such as an ester (compounds 9-16), a double ester (compounds 17-24), an imide (compounds 25-30)

  为了继续努力发现可释放一氧化氮的新型非甾体抗炎药（NO-NSAID）作为潜在的“安全NSAID”，我们在此报告了21种常用NSAID的新NO-NSAID的设计，合成和评估。如阿司匹林，双氯芬酸，萘普生，氟比洛芬，酮洛芬，舒林酸，布洛芬和消炎痛。这些前药具有可通过诸如酯（化合物9-16），双酯（化合物17-24），酰亚胺（化合物25-30）或酰胺（化合物31）之类的键连接到母体NSAID上的释放NO的二硫键。 -33）。在这些NO-NSAID中，含酯的NO-阿司匹林（9），NO-双氯芬酸（10），NO-萘普生（11）和含酰亚胺的NO-阿司匹林（25），NO-氟比洛芬（27）和NO-酮洛芬（28）已显示出良好的口服吸收，抗炎活性和NO释放特性，并保护大鼠免受NSAID引起的胃损伤。NO-阿司匹林化合物25与等摩尔剂量的阿司匹林进一步共同评估，显示出与阿司匹林相当的剂量依赖性药代动力学，胃黏膜前
• A general strategy to add diversity to ruthenium arene complexes with bioactive organic compounds via a coordinated (4-hydroxyphenyl)diphenylphosphine ligand
  作者：Lorenzo Biancalana、Lucinda K. Batchelor、Alice De Palo、Stefano Zacchini、Guido Pampaloni、Paul J. Dyson、Fabio Marchetti

  DOI：10.1039/c7dt02062g

  日期：——

  (4-hydroxyphenyl)diphenylphosphine, coordinated to the [Ru(η6-p-cymene)Cl2] fragment, allows a series of bioactive carboxylic acids to be introduced directly into the organometallic molecule. Evaluation of the compounds on human ovarian cancer cells reveals synergistic enhancements in their antiproliferative activity relative to their bioactive organic and organometallic precursors.

  （4-羟基苯基）二苯基膦，配位到的酯化的[Ru（η 6 - p -cymene）氯2 ]片段，允许一系列生物活性羧酸的直接引入有机金属分子。化合物对人卵巢癌细胞的评估显示，相对于其生物活性有机和有机金属前体，其抗增殖活性具有协同增强作用。
• Synthesis and characterisation of glucosamine–NSAID bioconjugates
  作者：Rachel A. Jones、Yann Thillier、Siva S. Panda、Nicole Rivera Rosario、C. Dennis Hall、Alan R. Katritzky

  DOI：10.1039/c4ob01681e

  日期：——

  Synthetic strategies to prepare non-steroidal anti-inflammatory drug–glucosamine bioconjugates.

  合成策略以制备非甾体抗炎药物 - 葡萄糖胺生物结合物。